Skip to main content

BVH company update

By Jamie Smith - 21 Nov 2017
Antaros partners in European biomarker project for liver disease

LITMUS, a pioneering 34 million Euro research collaboration to develop new and non-invasive biomarkers for better diagnoses of patients with the liver condition NAFLD is being launched today. The aim is also to support the development of more effective medical treatments. Antaros Medical is one of the partners and is responsible for advanced imaging including elastography and diffusion methodologies across nine European centers.

Read more here.